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ABSTRACT
Argonaute (AGO) proteins have a well-established
role in post-transcriptional regulation of gene ex-
pression as key component of the RNA silencing
pathways. Recent evidence involves AGO proteins
in mammalian nuclear processes such as transcrip-
tion and splicing, though the mechanistic aspects of
AGO nuclear functions remain largely elusive. Here,
by SILAC-based interaction proteomics, we identify
the chromatin-remodelling complex SWI/SNF as a
novel AGO2 interactor in human cells. Moreover, we
show that nuclear AGO2 is loaded with a novel class
of Dicer-dependent short RNAs (sRNAs), that we
called swiRNAs, which map nearby the Transcription
Start Sites (TSSs) bound by SWI/SNF. The knock-
down of AGO2 decreases nucleosome occupancy at
the first nucleosome located downstream of TSSs in
a swiRNA-dependent manner. Our findings indicate
that in human cells AGO2 binds SWI/SNF and a novel
class of sRNAs to establish nucleosome occupancy
on target TSSs.
INTRODUCTION
The first RNA interference (RNAi) phenomena were re-
ported ∼20 years ago in plants (1), fungi (2) and metazoa
(3). Key players in this process are sRNAs (19–24 nt), the
type III ribonuclease Dicer which is involved in sRNA pro-
cessing, and a widely conserved family of proteins called
Argonaute (AGO) (4). AGO proteins are primarily known
for their cytoplasmic function in post-transcriptional gene
silencing. In the cytosol, AGO proteins bind to a sRNA
molecule and to other proteins (TNRC6, TRBP), giving
rise to the RNA-Induced Silencing Complex (RISC) . The
sRNA guides the recruitment of the RISC complex onto
target RNA molecules by base-pair complementarity.
Growing evidence, however, indicates that AGO proteins
can also regulate nuclear processes in association with sR-
NAs (5). These mechanisms have been well-characterized
in Schizosaccharomyces pombe where AGO proteins partic-
ipate to the assembly of heterochromatin at centromeric re-
gions via histone methylation (6), and in plants where RNAi
directs establishment, spread and removal of DNA methyla-
tion (7). In the past few years, several studies have reported
that AGO proteins exert pivotal functions also in the nu-
clei of mammalian cells. In particular, AGO1 and/or AGO2
in association with exogenous and/or endogenous sRNAs
complementary to genomic target regions repress (8,9) or
activate gene expression (10,11), control alternative splicing
(12,13) and DNA repair (14,15).
The SWI/SNF (switch/sucrose non-fermentable) com-
plex is a highly conserved multi-subunit ATP-dependent
chromatin remodelling complex which alters the structure
and positioning of nucleosomes, thereby modulating the ac-
cess of regulatory proteins to DNA. In mammalian cells,
the canonical SWI/SNF complex contains one of the two
mutually exclusive ATPases, BRM (SMARCA2) or BRG1
(SMARCA4), a ‘core’ set of subunits consisting of BAF155
(BRG1-associated factor or SMARCC1), BAF47 (hSNF5
or INI1) and BAF170 (SMARCC2), as well as four to eight
other accessory subunits (16). Through chromatin remod-
elling, the SWI/SNF complex controls transcription, DNA
repair, recombination and chromosome segregation thus af-
fecting a variety of biological processes such as cell differ-
entiation, proliferation, development and malignant trans-
formation (17).
Recently, genome-wide ChIP-Seq analyses conducted on
different murine and human cell lineages have shown that
a considerable fraction of SWI/SNF binding sites resides
in functional genomic regions such as TSSs, enhancers,
CCCTC-binding factor (CTCF)-bound loci and many re-
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gions occupied by RNA Polymerase II (18–20). Consis-
tently, the SWI/SNF complex is capable of facilitating both
gene activation and repression probably by establishing and
maintaining the nucleosome landscape around TSSs (21).
Here, by using a SILAC-based interactomics approach
we identify the SWI/SNF complex as a novel interactor of
AGO2 in human cells. Moreover, we provide evidence of
the existence of a novel class of AGO2-associated sRNAs,
that we termed ‘swiRNAs’, which map nearby TSSs bound
by SWI/SNF and are processed in a Dicer-dependent man-
ner. We further demonstrate that AGO2 depletion results
in altered occupancy of nucleosome +1 downstream of
these TSSs. Our data provide the first evidence of a direct
crosstalk between AGO2 and the chromatin remodelling
machinery in human cells, suggesting a novel mechanism
of epigenetic regulation.
MATERIALS AND METHODS
Cell culture and transfection
HeLa S3, Jurkat and HEK293T cells were grown in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented
with 10% (v/v) foetal bovine serum, 2 mM L-glutamine and
penicillin–streptomycin. HCT116 WT and DicerEx5 cells
(22) were grown in McCoy’s 5A medium supplemented with
10% (v/v) foetal bovine serum, 2 mM L-glutamine and
penicillin–streptomycin.
Transfections were done with 10 nM siRNAs (siAGO2:
a pool containing the following siRNAs GCAGGA-
CAAAGAUGUAUAA[dT][dT] (23) and CGUCCGU-
GAAUUUGGAAUCAU[dT][dT] (Sigma); siCTRL:
AGCUUCAUAAGGCGCAUGC[dT][dT]) for 4 days
using INTERFERin R© as transfecting agent according to
the manufacturer’s instructions (Polyplus Transfection).
RNA isolation and RT-qPCR
RNA from HeLa S3, HCT116 WT and DicerEx5 cells was
isolated using TriReagent according to the manufacturer’s
protocol (Sigma).
For RT-qPCR, RNA was retrotranscribed using En-
hanced Avian Reverse Transcriptase (Sigma), and specific
reverse primers. Quantitative real-time PCR was performed
using SensiMix SYBR & Fluorescein Kit (Bioline) with
Biorad iCycler. Quantification was normalized to the small
nucleolar RNA U44.
Primer sequences are available under request.
Western blot
For western blot analyses the following antibodies were
used: anti-AGO1 (4B8, Ascenion), anti-AGO2 (11A9,
Ascenion), anti-GAPDH (14C10, Cell Signaling technol-
ogy), anti-histone H1 + core proteins (F152.C25.WJJ,
Millipore) anti--tubulinI (SAP.4G5, Sigma), anti-BRG1
(H-88, Santa Cruz), anti-BAF155 (Abcam), anti-INI1
(Bethyl Laboratoties), goat-anti mouse and anti-rabbit
IgG–HRP conjugated (Bio-Rad), anti-rat IgG–HRP con-
jugated (Jackson).
Chromatin binding assay
Chromatin binding assay was performed as previously de-
scribed (24). The equivalent of 1 × 106 cells of all fractions
were analysed by western blotting.
Preparation of total, nuclear and cytosolic cell extract
For total cell extract, cells lysed in immunoprecipitation
(IP)-buffer (150 mM KCl; 25 mM NaCl; 2 mM EDTA; 0.5%
NP40; 0.5 mM DTT; protease inhibitor (Sigma)) for 20 min
on ice. Lysate was clarified by centrifugation at 16 000 g for
10 min at 4◦C.
Cytosolic and nuclear extracts were prepared as follow-
ing: cells were resuspended, firstly, in one volume of ice-cold
buffer I (0.3 M sucrose in 60 mM KCl; 15 mM NaCl; 5 mM
MgCl2; 0.1 mM Ethylene Glycol Tetraacetic Acid; 15 mM
Tris–HCl pH 7.5; 0.5 mM DTT; protease inhibitors), then
added one volume of ice-cold buffer II (0.3 M sucrose in
60 mM KCl; 15 mM NaCl; 5 mM MgCl2; 0.1 mM EGTA;
15 mM Tris–HCl pH 7.5; 0.5 mM DTT, 0.4% NP-40, pro-
tease inhibitors), and placed on ice for 10 min. Afterwards,
cell lysate was layered on 24 ml of a sucrose cushion (1.2
M sucrose in 60 mM KCl; 15 mM NaCl; 5 mM MgCl2; 0.1
mM EGTA; 15 mM Tris–HCl pH 7.5; 0.5 mM DTT) and
centrifuged in a pre-chilled swing-out rotor at 10 000 g for
20 min at 4◦C. The upper phase containing the cytoplasmic
fraction was collect and the pellet containing cell nuclei was
lysed in IP-buffer and clarified.
Immunoprecipitation and co-immunoprecipitation
Antibodies anti-AGO1 (4B8, Ascenion); anti-AGO2
(11A9, Ascenion); anti-BAF155 (Abcam)) and isotype-
matched IgG (as mock IP) were coupled to protein-G-
sepharose beads (Sigma).
Whole-cell lysate (40-80 × 106 cells) or nuclear fraction
(60-160 × 106 cells) were incubated overnight at 4◦C with
antibodies-coupled beads. IP were washed once with IP-
buffer and three times with IP-wash buffer (50 mM Tris–
HCl, pH 7.5; 300 mM NaCl; 5 mM MgCl2; and 0.05% non-
idet P-40). Proteins were eluted from beads by boiling for 5
min in SDS-PAGE sample buffer (Sigma).
DNase I and RNase A treatment
HeLa S3 whole-cell lysate was incubated with or with-
out DNase I (Roche) or RNaseA (Sigma) for 1 h at 4◦C.
EDTA was then added to a final concentration of 10 mM
to stop reaction. Lysates treated with or without DNase I
or RNaseA were immunoprecipitated using anti-AGO2 an-
tibody or IgG, following the protocol previously described.
Nuclear RNA-immunoprecipitation (RIP)
Nuclei of HeLa S3, Jurkat, HCT116 WT and DicerEx5 cell
lines were lysed in IP-buffer supplemented with RNasin
(Promega). Nuclear lysates were pre-cleared in the presence
of protein G-sepharose beads for 2 h at 4◦C.
Antibodies and isotype-matched IgG (mock IP) were
coupled to protein G-sepharose beads in IP-buffer con-
taining 1 mg/ml heparin (Sigma). The pre-cleared lysate
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Figure 1. AGO2 interacts with components of SWI/SNF complex in human cell lines. (a) Schematic view of SILAC-based analysis of the AGO2 in-
teractome, carried out in forward (for) and reverse (rev) setup (upper panel). The scatter plot based on protein SILAC-ratios (Heavy/Light) in forward
and reverse experiments (x and y axes, respectively), shows that the outliers (true binders; blue) are in the top right quadrant, while background proteins
(unspecific binders; green) cluster around protein ratio 1:1 (0 on a logarithmic scale). (b) Experimental scatterplot of H/L protein ratios obtained in the
forward and reverse AGO2-IP SILAC experiment with HeLaS3 lysates. Components of SWI/SNF and TNRC6 complex are highlighted in dark and light
blue respectively, while the bait is in red. (c) HeLaS3 and HCT116 cell extracts were immunoprecipitated (IP) with AGO2 antibody or isotype-matched
immunoglobulins (IgG) as a negative control. (d) HeLaS3 and HCT116 cell extracts were immunoprecipitated with BAF155 antibody or IgG as a negative
control. (e) AGO1 does not interact with SWI/SNF complex in human cell lines. HeLaS3 cell extract was immunoprecipitated with AGO1 or BAF155
antibody (with IgG as a negative control). Input and IPs were immunoblotted with the indicated antibodies.
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Figure 2. AGO2 and SWI/SNF complex are associated with chromatin and interact in the nucleus in a RNA- and DNA-independent manner. (a) Whole
cell extract (C), triton-soluble protein (S1), chromatin-bound, nuclear-matrix-bound and insoluble protein (P1), DNase-released chromatin associated
protein (S2) and insoluble, cytoskeletal and nuclear matrix protein (P2) fractions corresponding to the same amount of HeLaS3 or HCT116 cells were
analysed by western blot for the presence of indicated proteins. -tubulin serves as a chromatin-unbound marker whereas histone H1 as chromatin-bound
marker. (b) Cytosolic and nuclear fractions of HeLaS3 cells were prepared. Fractionation efficiency was verified by western blot for the presence of GAPDH
(cytosolic marker) and H1 (nuclear marker) (Left panel). Nuclear lysates were immunoprecipitated with indicated antibodies or IgG as a negative control
(right panel). (c) Total cell extract pre-treated or not with RNase A (left panel) or DNase I (right panel) were immunoprecipitated with AGO2 antibody
or IgG as a negative control. Input and IPs were immunoblotted with the indicated antibodies.
(150 × 106 nuclei for AGO2–RIP or 350 × 106 cells for
AGO1–RIP) were incubated with antibody-coupled beads
overnight at 4◦C. RNA from Input and IP samples was
extracted by phenol:chloroform:isopropyl alcohol, after
DNaseI- and proteinase K-treatment, and precipitated in
ethanol.
Cell culture and SILAC (stable isotope labelling by amino
acids in cell culture) labelling
HeLa S3 and Jurkat cell lines were grown in SILAC DMEM
(PAA) and SILAC RPMI (Sigma), respectively. The SILAC
media were supplemented with 10% dialysed foetal bovine
serum (PAA), non-essential amino acids L-glutamine and
L-leucine (Sigma), penicillin/streptomycin and either unla-
belled amino acids (‘Light’, L-lysine and L-arginine, Sigma)
or isotope-labelled amino acids (‘Heavy’, L-lysine-13C6–
15N2 and L-arginine–13C6–15N4, Sigma/Isotec). Cells were
adapted for at least six generations to achieve complete
incorporation of the isotope-labelled amino acids before
they were propagated to a scale needed for IP (350 × 106
cells for HeLa S3 cells and 150 × 106 cells for Jurkat
cells). AGO2 IP was firstly performed using the lysate from
‘Heavy’ cells as input, whereas mock IP (IgG IP) was per-
formed using the the ‘Light’ cellular lysate. In a second
experiment, a labelling swap was performed. IP was per-
formed as previously described with the following differ-
ences: equal amounts of proteins from Heavy and Light
lysates were used for IP. Heavy and Light IP were mixed 1:1
before elution. The elution was performed twice by compe-
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Figure 3. Nuclear AGO2 is associated with a novel class of sRNAs arising from TSSs bound by SWI/SNF complex (swiRNAs). (a) Genomic annotation
of sRNA-Seq data (hg19). The histograms illustrate the sRNA classes identified in AGO2- or IgG-IP samples. The main RNA classes in the AGO2-IP
sample are represented by miRNAs followed by ‘other sRNAs’. (b) Size distribution of AGO2- and IgG-IP ‘other sRNAs’. The fraction of ‘other sRNAs’
in AGO2- or IgG-IP samples and corresponding length (nt) are plotted. (c and d) Percentage of ‘other sRNAs’ in AGO2- or IgG-IP samples mapping
within SWI/SNF biding sites (ENCODE ChIP-seq data) (c) or within 1 kb of TSSs of expressed genes (TSSs were defined by mRNA-seq) (d). (e and f)
Average per gene coverage of AGO2-associated ‘other sRNAs’ around TSSs with a SWI/SNF binding site (ENCODE ChIP-seq data) within ±1 kb (e)
and around TSSs without SWI/SNF binding sites (f). Average per gene coverage is defined as the sum of sRNAs mapping to a given position (relative to
TSS) divided by number of TSSs analysed. Only ‘other sRNAs’ lying within clusters of less than 50 molecules were considered. Red and blue represent
sRNAs in the sense and anti-sense orientation with respect to gene transcription, respectively.
tition using a molar excess of a synthetic AGO2 peptide (3
g/10 × 106 cells; GeneScript) in elution buffer (300 mM
NaCl, 50 mM Tris–HCl pH 8, 0.01% NP-40, 5 mM MgCl2)
for 1 h at 22◦C, 750 rpm. The eluates were cleaned up with
Micro Bio-Spin Chromatography Columns (Bio-Rad).
SDS-PAGE and protein digestion
Proteins eluted from the beads in the IP experiments were
separated on a 4–12% gradient Bis–Tris mini gel (Invit-
rogen). After Coomassie staining (Colloidal Blue Stain-
ing Kit, Invitrogen), each lane was cut in seven slices and
trypsin digested according to a previously described proto-
col (25). Briefly, upon destaining by incubation with 50%
acetonitrile/25 mM ammonium bicarbonate (NH4HCO3)
solution, followed by 100% acetonitrile for dehydration, gel
pieces were incubated with 10 mM dithiothreitol in 50 mM
NH4HCO3 for 60 min at 56◦C for cysteine reduction fol-
lowed by treatment with 55 mM iodoacetamide in 50 mM
NH4HCO3 for 45 min at room temperature, in dark, for
cysteines alkylation. After several rounds of washing with
50 mM NH4HCO3 and dehydrating with 100% acetonitrile,
trypsin was added to the gel slices and incubated overnight
at 37◦C. The next day tryptic mixture was acidified with 2
l of 50% trifluoroacetic acid solution and collected. Pep-
tides were further eluted by 30% acetonitrile, 3% trifluo-
roacetic acid and with 100% acetonitrile. Eluted peptides
were concentrated in a speed-vacuum centrifuge and solu-
bilized in 100 l of 0.1% formic acid, desalted and concen-
trated using reverse-phase C18 handmade nano-columns
(StageTips) (26). Samples were eluted from StageTips with
80% acetonitrile, lyophilized and re-suspended in 7 l of
0.1% formic acid for LC–MS/MS analysis.
Liquid chromatography and tandem mass spectrometry (LC-
MS/MS)
Nano-columns (15 cm long with 75 m inner diameter and
350 m outer diameter) were prepared by packing C18 resin
(ReproSil C18-AQ, 3 m Dr Maisch, Germany). The 5 l
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Figure 4. The number of AGO2-associated swiRNAs overlapping each TSS does not correlates with gene expression level. (a) Genome browser (USCS)
view of representative clusters of AGO2-associated swiRNAs in HelaS3 cells. swiRNAs map to TSSs overlapped by SWI/SNF binding sites. Reads corre-
sponding to AGO2-associated swiRNAs are red-coloured and orientation respect to reference genome is indicated for each read. SWI/SNF binding sites
are black-coloured (BAF155, BAF170, BRG1, BAF47. Data from ENCODE). (b) Bar height represents average gene expression of loci with TSS (±150
nt) overlapped by at least the indicated number of AGO2-bound swiRNAs (green), IgG-IPed ‘other sRNAs’ (black) and AGO1-associated ‘other sRNAs’
(purple) in HeLaS3 cells.
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of desalted peptides were injected in the nano-column at
500 nl/min and separated by nanoflow liquid chromatog-
raphy on an Agilent 1100 Series LC system (Agilent Tech-
nologies), on line with a LTQ-FT Ultra mass spectrometer
(Thermo Scientific). The gradient used for peptide separa-
tion was performed at a flow rate of 250 nl/min and was
0–36% over 120 min, followed by gradients of 36–60% for
10 min and 60–80% for 5 min. Solvent A was 0.1% formic
acid and 5% acetonitrile in ddH2O, and solvent B was 95%
acetonitrile with 0.1% formic acid. The mass spectrome-
ter was controlled by Xcalibur software (Thermo Scientific)
and operated in data-dependent acquisition mode, to au-
tomatically switch between MS and MS/MS scans. Survey
full scan MS spectra were acquired by the FT detector from
200 to 1650 m/z, then the five most intense ions with charge
2+ to 4+ were selected for fragmentation in the linear ion
trap by collision induced dissociation. Collision energy was
set to 35 eV. In the LTQ-FT Ultra, full scan MS spectra were
acquired at a target value (AGC) of 106 ions, with a resolu-
tion equal to 105 at 400 m/z.
Protein identification and quantification
Acquired spectra were matched in the human IPI database
version 1301 by MaxQuant (27) version 1.3.0.05, which per-
forms peak list generation, protein identification by An-
dromeda search engine (28) and protein quantitation based
on SILAC. Cysteine carbamidomethylation and methion-
ine oxidation were set as fixed and variable modification re-
spectively and a maximum of two missed cleavages were al-
lowed. Mass tolerance was set to 10 ppm for MS spectra
and 0.5 Da for MS/MS spectra. Protein and peptide false
discovery rate were set to 1%.
For each cell line, the forward and reverse experiments
were analysed together using the ‘match between runs’ op-
tion to increase the number of identified peptides. Upon
MaxQuant analysis, proteins identified by at least two pep-
tides, of which at least one unique, were considered as high
quality identification and further analysed if their ratio was
calculated based on at least two counts (ratio count (RC) >
1). In the case of redundancy in protein identification (pep-
tides matching to multiple protein groups), we report the
leading protein in the ‘protein groups’ output table from
MaxQuant.
Isolation of nucleosomal DNA by micrococcal nuclease
(MNase) digestion
Digestion of chromatin from untreated, siCTRL- or
siAGO2-treated HeLa S3 cells (2 × 106) was performed with
50 U of MNase (New England Biolabs) in 300 l of perme-
abilization buffer (15 mM Tris–HCl pH 7.4, 300 mM su-
crose, 60 mM KCl, 15 mM NaCl, 4 mM CaCl2, 0.5 mM
EGTA, 0.2% NP-40, 0.5 mM -mercaptoethanol) for 20
min at 37◦C. The reaction was stopped by addition of 300
ul of stop buffer (50 mM Tris–HCl pH 8, 20 mM EDTA,
1% SDS) for 2 min on ice. RNA was degraded with 75 g
RNase A for 1 h at 37◦C and cellular proteins digested with
30 g proteinase K for 1 h at 55◦C. Nucleosomal DNA was
purified by phenol:chloroform extraction and precipitated
in ethanol.
Library construction and sequencing
Library construction and sequencing was performed by the
Institute of Applied Genomics (IGA) Technology Services
(Italy). Samples were sequenced on an Illumina HiSeq2000.
mRNA sequencing analysis
Total mRNA was purified from HeLaS3 cells. The data were
submitted to ArrayExpress database and are available un-
der the following accession number: E-MTAB-2128.
Reads were aligned using TopHat 2.0.9 (29) and tran-
scripts were assembled with cufflinks (v 2.1.1) (30) with the
following options:
-g iGenome hg19 genes.gtf -M mask hg19.gtf -b hg19.fa
where:
iGenome hg19 genes.gtf contains annotation of known
transcripts (iGenome UCSC hg19);
mask hg19.gtf contains genomic coordinates of anno-
tated rRNAs and tRNAs;
hg19.fa is the fasta file containing sequence of the human
genome hg19.
Transcripts were merged using cuffcompare (2.1.1) (30)
using the -R option, to exclude from final report any tran-
script which was not overlapped by any fragment in our
RNA-seq dataset. We therefore ended up with a list of genes
expressed in HeLaS3 cells under our growth conditions. All
analyses conducted using TSS coordinates (sRNAs cover-
age, nucleosome occupancy) were restricted to the 21 265
loci expressed in HeLaS3 cells under our growth conditions.
No further filtering based on the level of expression of mR-
NAs was applied. Expression values in FPKM summarized
at gene level were used to compute average expression val-
ues reported in Figure 4b.
Small and long RNA sequencing analysis
The data were submitted to ArrayExpress database and are
available under the following accession numbers:
HeLaS3 nuclear AGO2 associated sRNAs: E-MTAB-
2084
HeLaS3 nuclear AGO1 associated sRNAs: E-MTAB-
2129
HCT116 and HCT116 DicerEx5 nuclear AGO2 associ-
ated sRNAs: E-MTAB-2056
Reads quality was checked using FastqC v0.10.1
(http://www.bioinformatics.babraham.ac.uk/projects/
fastqc/)
Sequences were quality trimmed (H.Li: https://github.
com/lh3/seqtk) and adapters were removed using cutadapt
v 1.0 (31)
Sequences were iteratively aligned to different databases
to identify RNAs which did not belong to any known
AGO2-associated class of RNA. After each alignement
round reads with no alignments were used in the next step.
Alignements were performed using Bowtie 0.12.7 (32) with
the following options: -n 0 -l 18 (requiring no mismatches
in the first 18 nt of the reads).
In a first step, reads were aligned to human miRNA hair-
pin precursors miRbase (v20.0) (33) to remove all reads
aligning to miRNA precursors.
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In a second step, unaligned reads were aligned against
rRNA and tRNA database to remove any reads aligning
to tRNA and ribosomal RNA.
In a third step, unaligned reads were aligned against a
manually cured Rfam database (34). Such manually cured
Rfam database includes all sequences included in Rfam
with the exception of those annotated as lincRNAs.
Finally, unaligned reads were mapped against the human
genome (hg19) using bowtie 0.12.7 (32) with the following
options: -n 0 -l 18 -m 1. RNAs mapping to a single locus
on hg19 at this step were called ‘other sRNAs’ and further
analysed.
‘Other sRNAs’ alignements were converted into
BED format for both AGO2 sample and IgG control
(AGO2 sRNAs.BED and IgG sRNAs.BED) and further
analysed using the bedtools package (35) as follows:
‘Other sRNAs’ were divided in clusters (requiring same
strandness) using mergeBed program (mergeBed -s); most
clusters consisted of less than 50 sRNAs, while a few hun-
dred clusters consisted of tens of thounsands of identical
reads. These high-copy clusters likely represent novel miR-
NAs or PCR artifacts. We therefore decided to focus our
attention on sRNAs in low copy clusters (<50 sRNAs) and
removed from AGO2 sRNAs.BED and IgG sRNAs.BED
reads lying into High-copy clusters (>50 reads).
To compute the overlap between sRNAs and other ge-
nomic features we calculated the fraction of ‘other sRNAs’
with at least one nt overlap with the feature of interest (e.g.
CpG islands) using intersectBed tool. Exact binomial test
was used to compute P-values, using the frequency of ‘other
sRNAs’ overlapping a given feature as the expected fre-
quency (null hypothesis).
coverageBed tool was used with the -s and -S options
to compute coverage of sense ‘other sRNAs’ and antisense
‘other sRNAs’ around each TSS. The TSS coordinates were
obtained by analysis of HeLaS3 mRNA-seq (see above).
For analysis of HCT116 and HCT116 DicerEx5 cells TSS of
human genes were retrieved from ENSEMBL human gene
annotation (version 69) (36). Occupancy profiles around
each TSS were piled up and normalized by the total number
of ‘other sRNAs’ to obtain the cumulative profile depicted
in Figures 3e, f and 5a, b.
In order to find putative dsRNA precursors of swiRNAs,
HeLaS3 long nuclear RNA-seq data sets were downloaded
from ENCODE (37) experiment matrix (GSM765403,
GSM767848).
The long Poly-A plus (two replicates) and Poly-A mi-
nus (two replicates) datasets were pooled together to in-
crease the sequencing depth. swiRNAs coordinates were
compared to long RNA coordinates with intersectBed
tool requiring that long RNA molecules derived from
sense/antisense transcription completely embedded the ma-
ture swiRNA.
Nuclear AGO1-associated sRNAs were analysed using
the same methodology outlined for AGO2.
4842 clusters of ‘other sRNAs’ consisting of >50 reads
were identified (3.9% of clusters) and reads lying within
these clusters were discarded from subsequent analyses.
To assess whether swiRNAs could arise from miRNA-
like hairpin precursors we extended swiRNA sequences by
70 nt on both sides and predicted secondary structures of
the resulting sequences with RNAfold. The obtained struc-
tures were parsed by a perl script requiring: (i) that at least
75% of the swiRNA nucleotides were paired in the result-
ing structure; (ii) that all paired nucleotides within the re-
sulting structure were belonging to a single stem structure;
(iii) that at least one of the three last nucleotides at each
end of the swiRNA was paired in the resulting structure.
Sequences satisfying all these conditions were scored as po-
tential miRNA-like hairpins. Human mature miRNAs from
miRbase v 20 were used as a positive control. Dinucleotide
shuffling of swiRNAs and mature miRNA were used as neg-
ative controls.
ChIP sequencing analysis
To compute the coverage of BRG1 and BAF47 ChIP exper-
iments raw data were downloaded from ENCODE (GEO
accession GSM935635, GSM935511), aligned to hg19 hu-
man genome using bowtie v 0.12.7. Average size of ChIP
fragments was calculated using macs14 software. Each
mapped read (in .bed format) was extended to the average
ChIP fragment length. Coverage at each nt around each
TSS was computed using coverageBed (35).
MNase sequencing analysis
592534546 reads were sequenced for AGO2 knock-down
sample
711051028 reads were sequenced for control sample
The data were submitted to ArrayExpress database and
are available under the following accession numbers: E-
MTAB-1844.
Sequence quality was assessed using FastQc v 0.10.1.
(http://www.bioinformatics.babraham.ac.uk/projects/
fastqc/)
Paired End reads were aligned using bowtie v 0.12.7 (32)
with options -n 1 -l 30 -m 1.
Only properly paired reads were further analysed. MNase
digestion is known to produce fragments of variable size;
however, shorter fragments (<100 nt) are likely to represent
the DNA footprint of transcription factors, polymerases
and other DNA binding proteins. The DNA footprint of
a nucleosome is expected to be about 146 nt long. However,
it is known that at low efficiency MNase may occasionally
nick the 146 nt long nucleosomal DNA at about 10 nt (one
DNA helix turn) into the nucleosome at each end, giving
rise to a small satellite population of 127 nt fragments which
do represent nucleosomes. DNA fragments longer than 200
nt are unlikely to represent bona fide nucleosome footprints.
We therefore selected paired end reads with a size between
100 and 200 nt.
After such selection, we obtained:
206561235 fragments for AGO2 knock-down sample
240239066 fragments for control sample
As a first control we checked size distribution of these
reads, and as expected we observe two sharp peaks at 128
and 147 nt (Supplementary Figure S6). Importantly, the
size distribution of control and AGO2 knock-down sam-
ples are extremely similar. This similarity confirms that the
two DNA samples were digested in comparable conditions.
Over-digestion of a sample compared to the other would
result in a higher 128 nt peak and a lower 147 nt peak.
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Nucleosome occupancy at the genomic loci of interest
was computed using coverageBed and a custom perl script
to determine cumulative occupancy over multiple loci. Oc-
cupancy was normalized by the total number of sequenced
nucleotides in each library taking into account properly
paired read pairs with a length between 100 and 200.
HeLaS3 TSS coordinates were based on RNA-seq anal-
ysis of mRNAs (see below). Occupancy profile at TSS over-
lapped by at least 30 swiRNAs (Figure 6c) was smoothed
using supsmu function in R statistical environment.
Nucleosome +1 occupancy was defined as the sum of
the coverage at each nucleotide position in the interval be-
tween nt +100 and nt +300 relative to TSS. For each group
of genes that were selected based on the minimum num-
ber of swiRNAs mapping within ±150 nt of TSS, a paired
Wilcoxon test was performed to compute P-value of the dif-
ference observed between average coverage at nucleosome
+1 in AGO2 knock-down and CTRL siRNA cells. For each
group of n genes (whose TSS were overlapped by at least m
swiRNAs) 10 000 random permutations were performed to
estimate FDR. In each permutation, n random genes were
chosen (among the 21 265 genes expressed in HeLaS3 cells)
and the P-value was computed comparing occupancy at nu-
cleosome +1 with the same procedure outlined above for the
real case.
GO term analysis
The Gorilla (38) online web tool was used to compute en-
riched GO terms in the ranked list of HeLaS3 expressed
genes. The list was ranked in decreasing order according to
the number of swiRNAs mapping within ±150 nt of TSS.
RESULTS
AGO2 interacts with SWI/SNF complex in the nucleus of
human cells
In order to identify novel AGO2 interactors in human cells,
we performed a SILAC-based proteomic analysis of pro-
teins that co-immunoprecipitate with AGO2 in HeLaS3
and Jurkat cell lines. Two independent biological replicates
were analysed for each cell line, with an isotope-labelling
swap (Figure 1a). As expected, well-known AGO2 interac-
tors (such as TNRC6 complex (39) and HSP90 (40)) were
enriched in AGO2 immunoprecipitates (AGO2-IP) rela-
tive to mock IP (IgG-IP). Surprisingly, the complete set
of SWI/SNF chromatin remodelling complex subunits was
also significantly enriched in AGO2-IP as measured by their
SILAC H/L protein ratio (Figure 1b, Supplementary Fig-
ure S1a–d and Table S1). Comparable results were obtained
in both cell lines (Supplementary Table S2). We confirmed
the enrichment of the core components of SWI/SNF com-
plex (BAF155, BRG1, BAF47) in AGO2-IP by western blot
in HeLaS3, HCT116 (Figure 1c), HEK293T and Jurkat
cells (Supplementary Figure S1e). Coherently, we were able
to pull down AGO2 by immunoprecipitating BAF155 (Fig-
ure 1d).
Since AGO1, another member of the AGO family, has
a well-established role in transcriptional regulation of gene
expression (9–11), we checked for an AGO1-SWI/SNF in-
teraction, but our data do not support this hypothesis (Fig-
ure 1e).
SWI/SNF mainly exerts its function on chromatin, there-
fore we verified whether AGO2 is also associated with chro-
matin in our experimental model. We found that not only
BAF155, but also AGO2 is associated with chromatin in
HeLaS3 and HCT116 cell lines by a chromatin binding as-
say (Figure 2a), in agreement with previous reports (11).
We next purified nuclei from HeLaS3 cells and verified that
AGO2 and BAF155 interact in the nuclear compartment
(Figure 2b).
Treatment with DNase I or RNase A before IP did not
disrupt AGO2-BAF155 interaction (Figure 2c and d and
Supplementary Figure S2), ruling out the possibility that
DNA and/or RNA bridge the association of AGO2 with
SWI/SNF.
Nuclear AGO2 is bound to a novel class of sRNAs
To better characterize the nuclear function of AGO2, we
profiled sRNAs specifically bound to nuclear AGO2 in
HeLaS3, Jurkat and HCT116 cells by massively parallel
high throughput sequencing (Figure 3 and Supplementary
Figure S3). To identify even low-abundant sRNA molecules
we attained a sequencing depth of 100 million reads per
sample (Supplementary Figure S4a), which is substantially
higher than the depth employed for the same type of anal-
ysis reported elsewhere (41,42).
By iteratively mapping AGO2-bound sRNAs on miR-
NAs, tRNAs, rRNAs and Rfam (34) we identified a class
of sRNAs, herein referred to as ‘other sRNAs’, which do
not align to any previously annotated sRNA classes (miR-
NAs, tRNAs, snRNA, snoRNA etc; Supplementary Fig-
ure S3a and Figure S3a–c). A bioinformatics analysis using
miRanalyzer (43) failed to identify putative novel miRNAs
among AGO2-bound ‘other sRNAs’. ‘Other sRNAs’ asso-
ciated with AGO2 display a size distribution peaking at 22–
24 nt, typical of AGO2-associated sRNAs (Figure 3b and
Supplementary Figure S3d–f), whereas mock-IPed ‘other
sRNAs’ have a heterogeneous size profile.
Typically, miRNA loci give rise to hundreds to thousands
of sRNA reads with nearly identical 3′ and 5′ termini. To
ascertain whether AGO2-associated ‘other sRNAs’ could
contain novel miRNAs which escaped the miRanalyzer al-
gorithm, we grouped ‘other sRNAs’ overlapping by at least
one nt into clusters. Only 0.86% of all clusters are miRNA-
like clusters. Four hundred one clusters (representing 27%
of these miRNA-like clusters) lie within ±500 nt of TSS of
protein coding genes, and might represent the human ho-
mologues of the 437 novel TSS-miRNAs reported in mouse
ESC (42). On the contrary, the vast majority of clusters
(99.14%) consists of <50 reads per cluster slightly differing
in 3′ and 5′ termini (low copy clusters). Therefore, we fo-
cused all subsequent analyses on ‘other sRNAs’ falling into
low copy clusters.
We compared the binding sites of SWI/SNF in HeLaS3
cells (20) with the genomic coordinates of ‘other sRNAs’.
We found that ‘other sRNAs’ mapping to SWI/SNF bind-
ing sites are enriched in AGO2-IP as compared to mock-
IP (P-value < 2.2 × 10−16, exact binomial test, Figure 3c).
We speculated whether this new class of sRNAs bound to
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/43/3/1498/2411320 by D
ip Biotecnologie C
ellulari user on 13 N
ovem
ber 2018
Nucleic Acids Research, 2015, Vol. 43, No. 3 1507
a
b
0.
00
0
0.
00
5
0.
01
0
sw
iR
N
A 
co
ve
ra
ge
Distance from TSS (nt)
-1000 -500 +1 +500 +1000
HCT116 DICEREx5
0.
00
0
0.
00
5
0.
01
0
sw
iR
N
A 
co
ve
ra
ge
 
-1000 -500 +1 +500 +1000
HCT116
sense antisense
Distance from TSS (nt)
c
Figure 5. swiRNAs are processed in a Dicer-dependent manner.Coverage of swiRNAs in parental HCT116 cell line (a) and in HCT116 DicerEx5 cell line
(b.) Coverage at each position represents the number of swiRNAs mapping at the indicated distance from a TSS, normalized by the total number of ‘other
sRNAs’. Only ‘other sRNAs’ lying within clusters of <50 molecules were considered. Red and blue represent sRNAs in the sense and anti-sense orientation
with respect to gene transcription, respectively. (c) swiRNAs display a 2 nt 3′ overhang typical of Dicer-processed sRNAs. The length (nt) of 3′ overhang
for pairs of complementary swiRNAs was plotted. Negative values represent a 5′ overhang. Most pairs display a 2 nt 3′ overhang, suggestive of Dicer
processing.
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Figure 6. AGO2 knock-down affects nucleosome occupancy at TSSs bound by SWI/SNF. (a) HeLaS3 cells were transfected with a control siRNA (siC-
TRL) or a pool of AGO2 siRNA (siAGO2). Down-regulation of AGO2 protein was verified by western blot. GAPDH was used as loading control. (b)
Chromatin from siCTRL- or siAGO2-treated HeLaS3 cells was digested by MNase and recovered DNA fragments were sequenced. Nucleosome occu-
pancy profile for siCTRL and siAGO2 cells was plotted for TSSs with at least 30 swiRNAs (siCTRL, black line; siAGO2, green line). The occupancy at
the nucleosome +1 (arrow) is reduced in AGO2 knock-down cells. (c) Bars height represents percent reduction of nucleosome occupancy (siAGO2 versus
siCTRL) at TSS ±150 nt overlapped by at least the indicated number of swiRNAs (green), IgG-IP ‘other sRNAs’ (black) and AGO1-associated ‘other
sRNAs’ (purple). **P value < 0.01, ***P value < 10−3, paired Wilcoxon test (see ’Materials and Methods’ section for details).
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AGO2 mapped nearby TSSs. In fact, it has been recently
shown that in HeLaS3 cells SWI/SNF is recruited in the
proximity of TSS of expressed genes (20). We found a spe-
cific enrichment of sRNAs mapping on TSS in AGO2-IP
relative to mock-IP (P-value < 2.2 × 10−16, exact binomial
test, Figure 3d and Supplementary Figure S3g–i). Interest-
ingly, ‘other sRNAs’ bound by AGO2 preferentially map
around TSSs bound by SWI/SNF (Figure 3e) as compared
to TSSs not bound by SWI/SNF (Figure 3f). AGO2-bound
‘other sRNAs’ lie on both the sense and anti-sense direction
with respect to gene transcription. These analyses clearly
show that nuclear AGO2 is loaded with sRNAs arising from
SWI/SNF bound TSSs. For this reason, we will herein refer
to nuclear AGO2-associated sRNAs mapping within ±150
nt of a TSS as swiRNAs (Figure 4a). We found 4549 TSSs
overlapped by at least one swiRNA. As expected, swiRNAs
co-localize with histone modifications which are typical of
open chromatin and TSS (H3K9ac, H2Az). However, while
we observe a positive correlation between swiRNA abun-
dance and the ChIP signal intensity of SWI/SNF compo-
nents (Supplementary Figure S4b), such correlation is not
observed for histone modifications (data not shown). Ac-
cordingly, although swiRNAs originate from transcription-
ally active TSSs, there is no correlation between the number
of swiRNAs overlapping a TSS and the expression level of
that locus (Figure 4b). On the other hand, IgG IPed sRNAs
mapping nearby TSSs correlate with the expression level
of the corresponding gene. This observation indicates that
swiRNA levels on a particular promoter are not under the
control of the same mechanisms regulating transcription of
that particular gene.
CLIP-seq approaches have recently been used to assess
the specificity of protein–RNA interactions in vivo. Typi-
cally, UV-crosslinked RNA molecules recovered from CLIP
experiments display single nucleotide substitutions, corre-
sponding to nucleotide positions crosslinked to the protein
of interest (44). We asked whether swiRNAs could be de-
tected in published AGO2 CLIP datasets. We employed the
same bioinformatics analysis described above on datasets
SRR363673–6 (44) in which AGO2 CLIP was used to iden-
tify the interacting sRNAs. To the best of our knowledge,
this is the only AGO2 CLIP dataset explicitly looking at
sRNAs bound to AGO2, rather than at target mRNAs.
Once we obtained the ‘other sRNAs’ in low copy clus-
ters, we divided them into two classes: those perfectly map-
ping to human genome, and hence lacking the ‘cross-linking
signature’ of CLIP (unCLIPPED), and those mapping
with one or more mismatches (which are bona-fide AGO2-
bound in vivo, CLIPPED). We found that ‘CLIPPED sR-
NAs’ represented the vast majority of the dataset (96.6%
of ‘other sRNAs in low copy clusters), corroborating the
idea that AGO2 actually binds these molecules in vivo.
Among CLIPPED ‘other sRNAs’ we found a proportion of
swiRNAs (11.0%) even higher than the one observed in our
HeLaS3 datasets (6.4%). Moreover, CLIPPED swiRNAs
from this dataset displayed a size distribution compatible
with AGO2 binding (data not shown). This analysis, al-
though at much lower depth, recapitulates what we ob-
served in our AGO2 and IgG RNA IP in HeLaS3, Jurkat
and HCT116 cell lines, further confirming that swiRNAs
are directly and specifically bound to AGO2 in vivo.
swiRNAs are processed by Dicer
In order to assess whether swiRNAs processing is
Dicer dependent, we characterized by RNA-seq nu-
clear AGO2-bound sRNAs in parental HCT116 cells
and in a Dicer hypomorphic subclone of HCT116 cells
(22) (HCT116DicerEX5). We observed a drastic reduction
of swiRNAs in HCT116DicerEX5 relative to parental
HCT116, indicating that Dicer processes swiRNAs (Figure
5a and b, Supplementary Figure S5). Dicer processes dou-
ble stranded RNA (dsRNA) molecules which may result
either by intramolecular pairing of an RNA molecule (e.g.
hairpin structures) or by pairing of two complementary
RNA molecules (e.g. pairing of RNAs transcribed from
opposite strands of the same locus). Using RNAfold (45)
we found that most swiRNAs are embedded in sequences
potentially able to form secondary structures. However,
analysis of the the predicted structures revealed that most
(78%) swiRNAs do not lie within a miRNA-like hairpin,
which is a prerequisite for DROSHA- and Dicer-mediated
miRNA processing. The same algorithm correctly scored
as miRNA-like structures most (77.4%) human miRNAs
(miRbase v20).
We therefore explored whether swiRNAs may be pro-
cessed from a dsRNA molecule arising from transcription
of both strands of the same locus. Taking advantage of the
HeLaS3 long RNA-seq dataset published by ENCODE,
we looked for putative dsRNA precursors of swiRNAs.
We found that ∼51% of the swiRNAs loci give rise to
long RNA molecules derived from sense/antisense tran-
scription. These RNA molecules embed the entire mature
swiRNA and may form a dsRNA suitable for processing by
Dicer. Since long noncoding RNA characterization in hu-
man cells is still incomplete, we do not exclude that a greater
depth of sequencing could unveil dsRNA precursors for all
swiRNAs. Dicer processes long dsRNAs producing short
dsRNAs characterized by a typical 3′ overhang of two nu-
cleotides. We found 2265 unique pairs of complementary
swiRNAs mapping on opposite strands of the same locus
and we looked at the 3′ termini of these pairs. Interestingly
we observed a strong bias toward a 2 nt 3′ overhang (Fig-
ure 5c), further confirming that Dicer plays a pivotal role in
swiRNA biogenesis.
Based on to the size, Dicer-mediated processing and asso-
ciation with AGO2, we conclude that swiRNAs are a novel
class of sRNAs distinct from any other class of sRNAs map-
ping near TSSs (41–42,46–48).
AGO2 depletion affects nucleosome positioning in a
swiRNA-dependent manner
The identification of novel interactions between AGO2,
core components of SWI/SNF and swiRNAs suggests the
involvement of AGO2 in SWI/SNF-mediated chromatin
remodelling. Therefore, we depleted AGO2 in HeLaS3 cells
by knock-down and performed MNase-Seq to assess nu-
cleosome positioning around TSSs in control and AGO2
knock-down cells (Figure 6a).
Paired end sequencing of MNase-digested DNA frag-
ments yielded ∼592 million reads in AGO2 knock-down
and ∼711 million reads in control cells. The size distribution
of DNA fragments is strikingly similar in the two samples,
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ruling out the possibility of a bias due to unequal digestion
(Supplementary Figure S6a–c). In our analysis we defined
nucleosome occupancy as the frequency with which a given
DNA region is occupied by a nucleosome within a cell pop-
ulation. We compared the average nucleosome occupancy
profiles around all TSSs of expressed genes among the two
samples; consistently with previous reports (49–51), we ob-
served in both samples a nucleosome-free region located im-
mediately upstream the TSS, flanked by two well-positioned
nucleosomes, referred to as −1 and +1 nucleosome. We did
not observe any changes in nucleosome phasing (data not
shown). On the contrary we found a mild (1.98%) but highly
significant (P-value = 1.5 × 10−15, paired t-test) decrease in
the average occupancy at nucleosome +1 in AGO2 knock-
down cells (data not shown). More interestingly, when we
looked at TSSs from which at least 30 swiRNAs are tran-
scribed, occupancy at nucleosome +1 was significantly af-
fected with 14% decrease (paired Wilcoxon test P-value =
0.0003723, FDR < 0.01) upon AGO2 depletion. This phe-
notype resembles the one observed in murine cells where
core components of SWI/SNF are genetically ablated (21),
suggesting that AGO2 and SWI/SNF not only physically
interact but also functionally cooperate in determining nu-
cleosome occupancy at TSS.
Moreover, AGO2-dependent reduction in nucleosome
occupancy positively correlated with the number of
swiRNAs mapping within ±150 nt from TSS (Figure 6b).
As a control, we performed the same analysis using IgG-
IP sRNAs for TSS selection (Figure 6b). In agreement with
the fact that AGO1 does not interact with SWI/SNF (Fig-
ure 1e), no correlation is observed between the number of
AGO1-associated sRNAs overlapping with each TSS and
occupancy reduction at nucleosome +1 in AGO2 knock-
down cells (Figure 6c; Supplementary Figure S6d).
A biological process GO term analysis of all genes
expressed in HeLaS3 sorted by decreasing number of
swiRNAs sheds light on the function of genes whose nu-
cleosome occupancy is affected by AGO2 depletion (Sup-
plementary Table S3). Top scoring enriched GO terms pin-
point at nucleic acid and protein metabolism.
These data suggest that swiRNA, AGO2 and SWI/SNF
collaborate to determine nucleosome occupancy at TSS of
genes involved in key metabolic pathways.
DISCUSSION
By a SILAC-based quantitative proteomic analysis, we
characterized the endogenous AGO2 interactome. In in-
teraction studies quantitative proteomic approaches have
the potential to easily distinguish true protein:protein in-
teractions from experimental contaminants by allowing the
accurate relative quantification of protein abundance in
both control and test immunoprecipitation samples (52–
54). Taking advantage of this powerful approach, we de-
scribe a physical and functional interplay between compo-
nents of the RNAi and chromatin remodelling machiner-
ies in human cells for the first time. Indeed, we show that
nuclear AGO2 interacts with SWI/SNF, and a new class
of sRNAs that we termed swiRNAs. These novel endoge-
nous, Dicer-dependent sRNAs arise from SWI/SNF bound
TSSs and determine nucleosome occupancy on target TSSs,
likely by recruiting nuclear AGO2–SWI/SNF complexes
onto specific TSSs.
swiRNAs do not overlap with any of the reported classes
of sRNAs and therefore represent a novel class of sR-
NAs. In fact, unlike tiRNAs (48) and TSSa RNAs (41,46),
swiRNAs have a peak size of 22–24 nt, are processed from
long dsRNA precursors by Dicer and are associated with
AGO2 in the nuclear compartment. Interestingly swiRNAs
are directly bound to AGO2 in vivo, as shown by AGO2
CLIP datasets analysis, demonstrating that swiRNAs are
not a mere by-product of transcription. This is in agreement
with the finding that gene expression level does not corre-
late to the number of swiRNAs mapping nearby each TSS.
Therefore, their abundance and stability might be regu-
lated by specific molecular mechanisms in response to intra-
and/or extra-cellular signals.
Based on our sequencing data, we estimate that swiRNAs
are on average 10 000-fold less abundant than miRNAs.
However, a miRNA has about a hundred of target mRNA
species, often with multiple binding sites for each target.
On the contrary, a swiRNA has a single possible genomic
target, present in two copies per cell. Indeed, even a sin-
gle swiRNA molecule per TSS would suffice to drive re-
cruitment of AGO2–SWI/SNF and affect nucleosome po-
sitioning, as shown by our data. It is worth mentioning that
swiRNAs could be selectively expressed in specific phases
of cell cycle. Moreover, they might be 5′ and/or 3′ modified
and our standard cloning conditions which are optimized
for unmodified small RNA molecules could underestimate
swiRNA abundance.
In eukaryotes, nucleosome occupancy around TSS of ac-
tively transcribed genes is characterized by a typical pat-
tern consisting of a nucleosome free region immediately up-
stream of TSS and a very well positioned +1 nucleosome im-
mediately downstream of TSS. It has been recently shown
that genetic ablation of key subunits of SWI/SNF in murine
cells specifically reduces nucleosome occupancy at TSS, sug-
gesting that SWI/SNF function is especially relevant for the
proper positioning of nucleosomes around TSS (21). Our
data highlight that depletion of AGO2 in human cells de-
creases nucleosome +1 occupancy and this positively corre-
lates with the number of swiRNAs mapping around a par-
ticular TSS. These observations support the idea that in
mammalian cells SWI/SNF complex specifically controls
nucleosome +1 occupancy in cooperation with AGO2 and
swiRNAs.
The widespread conservation across eukaryotes of a typ-
ical nucleosome occupancy pattern around actively tran-
scribed TSSs (49) is suggestive of a functional role for
such pattern. Previous reports highlight that occupancy at
nucleosome +1 is not predictive of gene expression level
(55). Accordingly, transcriptome analysis upon depletion
of AGO2 failed to reveal any significant change in steady-
state expression level of the genes displaying higher numbers
of swiRNAs, or any other apparent alteration of mRNA
expression (data not shown). Although several hypothe-
ses have been proposed, the exact functional role of nu-
cleosome occupancy at nucleosome +1 still remains elu-
sive. It has been previously suggested that nucleosome oc-
cupancy pattern in promoters might be related to plastic-
ity in gene expression (56). Prompted by our observation
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that swiRNA-enriched genes are mainly involved in pro-
tein and nucleic acid metabolisms, we speculate that such
genes might share a common mechanism to fine tune their
expression in response to environmental and cellular condi-
tions (i.e. cell cycle progression, growth signals or metabolic
stress). Proper occupancy at nucleosome +1 could play a
role in the response to stimuli or changes in environmen-
tal conditions that require a rapid and prompt adaptation
of cell metabolic rates. Further investigation of the cellular
outcome of AGO2 depletion might shed light on the physi-
ological consequences of altered occupancy at nucleosome
+1.
We propose that swiRNAs mediate recruitment of AGO2
and SWI/SNF onto targeted TSS, thus contributing to
proper positioning of nucleosome +1. This is the first
demonstration that the involvement of RNAi in chromatin
remodelling is conserved not only in plants and fungi but
also in mammals. Interestingly, both AGO2 and SWI/SNF
have been previously independently reported to be involved
in DNA damage response (15,54) and in alternative splicing
(13,56). Our data are suggestive of a functional interplay of
AGO2 and SWI/SNF in these processes and represent an
important starting point for further investigations.
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